Position history for GOLDMAN SACHS GROUP INC's holdings in VANECK PHARMACEUTICAL
GOLDMAN SACHS GROUP INC holds 986,112 shares of PPH (VANECK PHARMACEUTICAL), worth $102.4M as of 2026-Q1. The position was increased (+20.7% shares). PPH represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.
Current Value
$102.4M
Current Shares
986,112
Total Value Change
-$95.3M
Total Shares Change
-1.3M
Other major holders of PPH: Phoenix Financial Ltd., CITIGROUP INC, Fisher Asset Management, LLC
Increased |
| 986,112 |
+20.7% |
| $102.4M |
| 0.0% |
| $108.58 |
36 |
| 2025-Q4 | Decreased | 817,282 | -56.9% | $84.3M | 0.0% | $103.77 | 0 |
| 2025-Q3 | Decreased | 1.9M | -31.3% | $171.4M | 0.0% | $86.69 | 0 |
| 2025-Q2 | Increased | 2.8M | +138.1% | $243M | 0.0% | $86.23 | 50 |
| 2025-Q1 | Decreased | 1.2M | -49.4% | $105.7M | 0.0% | $88.85 | 0 |
| 2024-Q4 | New | 2.3M | - | $197.7M | 0.0% | $84.32 | 42 |